ElaineCSiegfriedMD

Dermatology • Saint Louis, MO

Pediatric Dermatology

Professor of Pediatrics and Dermatology Saint Louis U School of Medicine Cardinal Glennon Childrens Hosp

Join to view full profile

Dr. Siegfried is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Siegfried's full profile

Already have an account?

Office
1465 S Grand Blvd
Saint Louis, MO 63104
Phone+1 314-577-3450

Fax+1 314-268-4077

Education & Training

University of Iowa Hospitals and ClinicsResidency, Dermatology, 1988 - 1991
University of Iowa Hospitals and ClinicsResidency, Pediatrics, 1985 - 1988
University of Missouri-Columbia School of MedicineClass of 1985

Certifications & Licensure

MO State Medical License 1992 - 2025
IL State Medical License 1990 - 2002
IA State Medical License 1985 - 1994
American Board of Dermatology Dermatology
American Board of Dermatology Pediatric Dermatology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Top MD Consumers Checkbook

Clinical Trials

Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3

Publications & Presentations

PubMed

Live Attenuated Vaccine Administration in Children Treated With Methotrexate or Dupilumab.
Julia R Hughes, Sino Mehrmal, Sana Habib, Howard L Williams, Elaine C Siegfried
Pediatric Dermatology. 2024-12-11
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 Weeks.
Amy S Paller, Pedro Mendes-Bastos, Elaine Siegfried, Lawrence F Eichenfield, Weily Soong
JAMA Dermatology. 2024-12-01
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials.
Adelaide A Hebert, Carsten Flohr, H Chih-Ho Hong, Alan D Irvine, Evangeline Pierce
The Journal of Dermatological Treatment. 2024-12-01

Journal Articles

Pediatric Dermatology Workforce in the United States
Brea Prindaville, Kimberly A Horii, Elaine C Siegfried, Pediatric Dermatology

Press Mentions

The Many Ways to Measure the Severity of Atopic DermatitisApril 10th, 2023
Study Evaluates OTC Treatments for Molluscum ContagiosumAugust 27th, 2021
St. Louis Character: How Saint Louis University's Dr. Daniel Hoft Became One of the Nation's Leading Vaccine ExpertsJune 10th, 2021
Join now to see all